TY  - GEN
AU  - Pagès,F
AU  - André,T
AU  - Taieb,J
AU  - Vernerey,D
AU  - Henriques,J
AU  - Borg,C
AU  - Marliot,F
AU  - Ben Jannet,R
AU  - Louvet,C
AU  - Mineur,L
AU  - Bennouna,J
AU  - Desrame,J
AU  - Faroux,R
AU  - Kirilovsky,A
AU  - Duval,A
AU  - Laurent-Puig,P
AU  - Svrcek,M
AU  - Hermitte,F
AU  - Catteau,A
AU  - Galon,J
AU  - Emile,J-F
TI  - Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
SN  - 1569-8041
PY  - 2021///0106
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Chemotherapy, Adjuvant
KW  - Cohort Studies
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Duration of Therapy
KW  - Fluorouracil
KW  - France
KW  - Humans
KW  - Neoplasm Staging
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Prognosis
KW  - Prospective Studies
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.annonc.2020.03.310
ER  -